Eintrag weiter verarbeiten
276. Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy
Gespeichert in:
| Zeitschriftentitel: | Molecular Therapy |
|---|---|
| Personen und Körperschaften: | , , , , , , , |
| In: | Molecular Therapy, 24, 2016, S. S110 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Elsevier BV
|
| Schlagwörter: |
| author_facet |
Lebkowski, Jane S. Khoury, Hanna J. Collins, Robert H. Blum, William Stiff, Patrick Wirth, Edward Nishimoto, Kevin DiPersio, John Lebkowski, Jane S. Khoury, Hanna J. Collins, Robert H. Blum, William Stiff, Patrick Wirth, Edward Nishimoto, Kevin DiPersio, John |
|---|---|
| author |
Lebkowski, Jane S. Khoury, Hanna J. Collins, Robert H. Blum, William Stiff, Patrick Wirth, Edward Nishimoto, Kevin DiPersio, John |
| spellingShingle |
Lebkowski, Jane S. Khoury, Hanna J. Collins, Robert H. Blum, William Stiff, Patrick Wirth, Edward Nishimoto, Kevin DiPersio, John Molecular Therapy 276. Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy Drug Discovery Pharmacology Genetics Molecular Biology Molecular Medicine |
| author_sort |
lebkowski, jane s. |
| spelling |
Lebkowski, Jane S. Khoury, Hanna J. Collins, Robert H. Blum, William Stiff, Patrick Wirth, Edward Nishimoto, Kevin DiPersio, John 1525-0016 Elsevier BV Drug Discovery Pharmacology Genetics Molecular Biology Molecular Medicine http://dx.doi.org/10.1016/s1525-0016(16)33085-4 276. Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy Molecular Therapy |
| doi_str_mv |
10.1016/s1525-0016(16)33085-4 |
| facet_avail |
Online Free |
| finc_class_facet |
Chemie und Pharmazie Biologie Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMTUyNS0wMDE2KDE2KTMzMDg1LTQ |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMTUyNS0wMDE2KDE2KTMzMDg1LTQ |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
| imprint |
Elsevier BV, 2016 |
| imprint_str_mv |
Elsevier BV, 2016 |
| issn |
1525-0016 |
| issn_str_mv |
1525-0016 |
| language |
English |
| mega_collection |
Elsevier BV (CrossRef) |
| match_str |
lebkowski2016276longtermrelapsefreesurvivalofpatientswithacutemyeloidleukemiaamlreceivingatelomeraseengineereddendriticcellimmunotherapy |
| publishDateSort |
2016 |
| publisher |
Elsevier BV |
| recordtype |
ai |
| record_format |
ai |
| series |
Molecular Therapy |
| source_id |
49 |
| title |
276. Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy |
| title_unstemmed |
276. Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy |
| title_full |
276. Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy |
| title_fullStr |
276. Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy |
| title_full_unstemmed |
276. Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy |
| title_short |
276. Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy |
| title_sort |
276. long-term relapse-free survival of patients with acute myeloid leukemia (aml) receiving a telomerase-engineered dendritic cell immunotherapy |
| topic |
Drug Discovery Pharmacology Genetics Molecular Biology Molecular Medicine |
| url |
http://dx.doi.org/10.1016/s1525-0016(16)33085-4 |
| publishDate |
2016 |
| physical |
S110 |
| description |
|
| container_start_page |
0 |
| container_title |
Molecular Therapy |
| container_volume |
24 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792325793544667145 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T12:11:15.495Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=276.+Long-Term+Relapse-Free+Survival+of+Patients+with+Acute+Myeloid+Leukemia+%28AML%29+Receiving+a+Telomerase-Engineered+Dendritic+Cell+Immunotherapy&rft.date=2016-05-01&genre=article&issn=1525-0016&volume=24&pages=S110&jtitle=Molecular+Therapy&atitle=276.+Long-Term+Relapse-Free+Survival+of+Patients+with+Acute+Myeloid+Leukemia+%28AML%29+Receiving+a+Telomerase-Engineered+Dendritic+Cell+Immunotherapy&aulast=DiPersio&aufirst=John&rft_id=info%3Adoi%2F10.1016%2Fs1525-0016%2816%2933085-4&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792325793544667145 |
| author | Lebkowski, Jane S., Khoury, Hanna J., Collins, Robert H., Blum, William, Stiff, Patrick, Wirth, Edward, Nishimoto, Kevin, DiPersio, John |
| author_facet | Lebkowski, Jane S., Khoury, Hanna J., Collins, Robert H., Blum, William, Stiff, Patrick, Wirth, Edward, Nishimoto, Kevin, DiPersio, John, Lebkowski, Jane S., Khoury, Hanna J., Collins, Robert H., Blum, William, Stiff, Patrick, Wirth, Edward, Nishimoto, Kevin, DiPersio, John |
| author_sort | lebkowski, jane s. |
| container_start_page | 0 |
| container_title | Molecular Therapy |
| container_volume | 24 |
| description | |
| doi_str_mv | 10.1016/s1525-0016(16)33085-4 |
| facet_avail | Online, Free |
| finc_class_facet | Chemie und Pharmazie, Biologie, Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMTUyNS0wMDE2KDE2KTMzMDg1LTQ |
| imprint | Elsevier BV, 2016 |
| imprint_str_mv | Elsevier BV, 2016 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
| issn | 1525-0016 |
| issn_str_mv | 1525-0016 |
| language | English |
| last_indexed | 2024-03-01T12:11:15.495Z |
| match_str | lebkowski2016276longtermrelapsefreesurvivalofpatientswithacutemyeloidleukemiaamlreceivingatelomeraseengineereddendriticcellimmunotherapy |
| mega_collection | Elsevier BV (CrossRef) |
| physical | S110 |
| publishDate | 2016 |
| publishDateSort | 2016 |
| publisher | Elsevier BV |
| record_format | ai |
| recordtype | ai |
| series | Molecular Therapy |
| source_id | 49 |
| spelling | Lebkowski, Jane S. Khoury, Hanna J. Collins, Robert H. Blum, William Stiff, Patrick Wirth, Edward Nishimoto, Kevin DiPersio, John 1525-0016 Elsevier BV Drug Discovery Pharmacology Genetics Molecular Biology Molecular Medicine http://dx.doi.org/10.1016/s1525-0016(16)33085-4 276. Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy Molecular Therapy |
| spellingShingle | Lebkowski, Jane S., Khoury, Hanna J., Collins, Robert H., Blum, William, Stiff, Patrick, Wirth, Edward, Nishimoto, Kevin, DiPersio, John, Molecular Therapy, 276. Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy, Drug Discovery, Pharmacology, Genetics, Molecular Biology, Molecular Medicine |
| title | 276. Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy |
| title_full | 276. Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy |
| title_fullStr | 276. Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy |
| title_full_unstemmed | 276. Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy |
| title_short | 276. Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy |
| title_sort | 276. long-term relapse-free survival of patients with acute myeloid leukemia (aml) receiving a telomerase-engineered dendritic cell immunotherapy |
| title_unstemmed | 276. Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy |
| topic | Drug Discovery, Pharmacology, Genetics, Molecular Biology, Molecular Medicine |
| url | http://dx.doi.org/10.1016/s1525-0016(16)33085-4 |